Johnson & Johnson Xencor Inc Transaction History
Johnson & Johnson
- $475 Million
- Q1 2024
A detailed history of Johnson & Johnson transactions in Xencor Inc stock. As of the latest transaction made, Johnson & Johnson holds 748,062 shares of XNCR stock, worth $14.2 Million. This represents 3.49% of its overall portfolio holdings.
Number of Shares
748,062
Previous 748,062
-0.0%
Holding current value
$14.2 Million
Previous $15.1 Million
9.83%
% of portfolio
3.49%
Previous 5.83%
Shares
1 transactions
Others Institutions Holding XNCR
# of Institutions
203Shares Held
64MCall Options Held
2.2KPut Options Held
1.3K-
Black Rock Inc. New York, NY11.1MShares$209 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA9.09MShares$172 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.01MShares$133 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$101 Million3.36% of portfolio
-
State Street Corp Boston, MA4.24MShares$80.2 Million0.0% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.13B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...